{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:01:30Z","timestamp":1791475290925,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cct.2026.108219","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:23:34Z","timestamp":1767889414000},"page":"108219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The long-term effectiveness of the anti-obesity medication phentermine (LEAP) trial: Rationale, design, and baseline characteristics"],"prefix":"10.1016","volume":"161","author":[{"given":"Caroline Blackwell","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Rives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Gudzune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron C.","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney G.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian N.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Hooker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah B.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah R.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Vesely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly D.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Martin-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Inzhakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Pajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamy D.","family":"Ard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina H.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cct.2026.108219_bb0005","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jama.2020.14590","article-title":"Trends in obesity prevalence by race and Hispanic Origin-1999-2000 to 2017-2018","volume":"324","author":"Ogden","year":"2020","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.cct.2026.108219_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2012.113905","article-title":"Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis","volume":"309","author":"Flegal","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cct.2026.108219_bb0015","doi-asserted-by":"crossref","first-page":"w822","DOI":"10.1377\/hlthaff.28.5.w822","article-title":"Annual medical spending attributable to obesity: payer-and service-specific estimates","volume":"28","author":"Finkelstein","year":"2009","journal-title":"Health Aff. (Millwood)."},{"issue":"25 Suppl 2","key":"10.1016\/j.cct.2026.108219_bb0020","first-page":"S102","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the Obesity Society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cct.2026.108219_bb0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/oby.20967","article-title":"NIH working group report: innovative research to improve maintenance of weight loss","volume":"23","author":"MacLean","year":"2015","journal-title":"Obesity (Silver Spring)"},{"issue":"1 Suppl","key":"10.1016\/j.cct.2026.108219_bb0030","doi-asserted-by":"crossref","first-page":"222s","DOI":"10.1093\/ajcn\/82.1.222S","article-title":"Long-term weight loss maintenance","volume":"82","author":"Wing","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.cct.2026.108219_bb0035","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an endocrine society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 3","key":"10.1016\/j.cct.2026.108219_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr. Pract."},{"issue":"5","key":"10.1016\/j.cct.2026.108219_bb0045","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2022.08.045","article-title":"AGA clinical practice guideline on pharmacological interventions for adults with obesity","volume":"163","author":"Grunvald","year":"2022","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.cct.2026.108219_bb0050","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/oby.22581","article-title":"Antiobesity medication use in 2.2 million adults across eight large health care organizations: 2009-2015","volume":"27","author":"Saxon","year":"2019","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"10.1016\/j.cct.2026.108219_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12609","article-title":"Use of medications associated with weight change among participants in the all of us research programme","volume":"13","author":"Almazan","year":"2023","journal-title":"Clin. Obes."},{"issue":"11","key":"10.1016\/j.cct.2026.108219_bb0060","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jama.2018.7777","article-title":"Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: updated evidence report and systematic review for the US preventive services task force","volume":"320","author":"LeBlanc","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.cct.2026.108219_bb0065","series-title":"An Historical Review of Steps and Missteps in the Discovery of Anti-Obesity Drugs","author":"Bray","year":"2025"},{"issue":"2","key":"10.1016\/j.cct.2026.108219_bb0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1517\/14740338.2015.995088","article-title":"Why are anti-obesity drugs stigmatized?","volume":"14","author":"Halpern","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.cct.2026.108219_bb0075","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/ANNALS-24-02870","article-title":"Trends in utilization of glucose- and weight-lowering medications after Tirzepatide approval in the United States\u202f: a population-based cohort study","volume":"178","author":"Ostrominski","year":"2025","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"10.1016\/j.cct.2026.108219_bb0080","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/oby.22307","article-title":"Coverage for obesity prevention and treatment services: analysis of Medicaid and state employee health insurance programs","volume":"26","author":"Jannah","year":"2018","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"10.1016\/j.cct.2026.108219_bb0085","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/oby.23725","article-title":"Estimated minimum prices and lowest available national prices for antiobesity medications: improving affordability and access to treatment","volume":"31","author":"Levi","year":"2023","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.cct.2026.108219_bb0090","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s13679-023-00546-9","article-title":"Phentermine in the modern era of obesity pharmacotherapy: does it still have a role in treatment?","volume":"13","author":"Lewis","year":"2024","journal-title":"Curr. Obes. Rep."},{"issue":"4","key":"10.1016\/j.cct.2026.108219_bb0100","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/oby.22430","article-title":"Safety and effectiveness of longer-term phentermine use: clinical outcomes from an electronic health record cohort","volume":"27","author":"Lewis","year":"2019","journal-title":"Obesity (Silver Spring)"},{"issue":"8","key":"10.1016\/j.cct.2026.108219_bb0105","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/oby.22516","article-title":"Knowledge gaps in long-term phentermine use: making the case for maintenance","volume":"27","author":"Murali","year":"2019","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10.1016\/j.cct.2026.108219_bb0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ijo.2013.74","article-title":"Addiction potential of phentermine prescribed during long-term treatment of obesity","volume":"38","author":"Hendricks","year":"2014","journal-title":"Int. J. Obes."},{"issue":"10","key":"10.1016\/j.cct.2026.108219_bb0115","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/gerona\/61.10.1059","article-title":"The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study","volume":"61","author":"Goodpaster","year":"2006","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"9","key":"10.1016\/j.cct.2026.108219_bb0120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","article-title":"Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies","volume":"14","author":"Batsis","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cct.2026.108219_bb0125","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2025","journal-title":"J. Biomed. Inform."},{"issue":"2","key":"10.1016\/j.cct.2026.108219_bb0130","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"issue":"21","key":"10.1016\/j.cct.2026.108219_bb0135","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2018.6360","article-title":"Randomization in clinical trials: permuted blocks and stratification","volume":"319","author":"Broglio","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cct.2026.108219_bb0140","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the systolic blood pressure intervention trial (SPRINT)","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin. Trials"},{"issue":"4","key":"10.1016\/j.cct.2026.108219_bb0145","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2337\/diacare.29.04.06.dc05-1729","article-title":"The association among autonomic nervous system function, incident diabetes, and intervention arm in the diabetes prevention program","volume":"29","author":"Carnethon","year":"2006","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.cct.2026.108219_bb0150","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2337\/dc10-0125","article-title":"Effects of cardiac autonomic dysfunction on mortality risk in the action to control cardiovascular risk in diabetes (ACCORD) trial","volume":"33","author":"Pop-Busui","year":"2010","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.cct.2026.108219_bb0155","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/CIRCULATIONAHA.104.496091","article-title":"Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women: the Women\u2019s Health Initiative","volume":"113","author":"Rautaharju","year":"2006","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cct.2026.108219_bb0160","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1360-0443.1995.9056072.x","article-title":"The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users","volume":"90","author":"Gossop","year":"1995","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.cct.2026.108219_bb0165","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12877-019-1182-3","article-title":"The severity of dependence scale detects medication misuse and dependence among hospitalized older patients","volume":"19","author":"Cheng","year":"2019","journal-title":"BMC Geriatr."},{"issue":"2","key":"10.1016\/j.cct.2026.108219_bb0170","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/sj.ejcn.1601768","article-title":"Relation between food intake and visual analogue scale ratings of appetite and other sensations in healthy older and young subjects","volume":"58","author":"Parker","year":"2004","journal-title":"Eur. J. Clin. Nutr."},{"issue":"8","key":"10.1016\/j.cct.2026.108219_bb0175","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.cct.2026.108219_bb0180","series-title":"Anthropometry Procedures Manual","author":"National Health and Nutrition Examination Study (NHANES)","year":"2025"},{"issue":"6","key":"10.1016\/j.cct.2026.108219_bb0185","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0091-7435(87)90022-3","article-title":"The development of scales to measure social support for diet and exercise behaviors","volume":"16","author":"Sallis","year":"1987","journal-title":"Prev. Med."},{"issue":"5","key":"10.1016\/j.cct.2026.108219_bb0190","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1037\/0022-006X.59.5.739","article-title":"Self-efficacy in weight management","volume":"59","author":"Clark","year":"1991","journal-title":"J. Consult. Clin. Psychol."},{"issue":"12","key":"10.1016\/j.cct.2026.108219_bb0195","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/oby.20368","article-title":"Development and validation of the weight control strategies scale","volume":"21","author":"Pinto","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.cct.2026.108219_bb0200","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1037\/adb0000136","article-title":"Development of the Yale food addiction scale version 2.0","volume":"30","author":"Gearhardt","year":"2016","journal-title":"Psychol. Addict. Behav."},{"issue":"6","key":"10.1016\/j.cct.2026.108219_bb0205","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"Sherbourne CD: the MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med. Care"},{"issue":"1","key":"10.1016\/j.cct.2026.108219_bb0210","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","article-title":"The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups","volume":"32","author":"McHorney","year":"1994","journal-title":"Med. Care"},{"issue":"3","key":"10.1016\/j.cct.2026.108219_bb0215","doi-asserted-by":"crossref","DOI":"10.5502\/ijw.v6i3.526","article-title":"The PERMA-profiler: a brief multidimensional measure of flourishing","volume":"6","author":"Butler","year":"2016","journal-title":"Int. J. Wellbeing"},{"key":"10.1016\/j.cct.2026.108219_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154388","article-title":"Factors affecting weight loss variability in obesity","volume":"113","author":"Dent","year":"2020","journal-title":"Metabolism"},{"issue":"12","key":"10.1016\/j.cct.2026.108219_bb0225","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jama.2020.14545","article-title":"Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018","volume":"324","author":"Muntner","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cct.2026.108219_bb0230","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/0962280212465500","article-title":"Analysing cognitive test data: distributions and non-parametric random effects","volume":"25","author":"Muniz-Terrera","year":"2016","journal-title":"Stat. Methods Med. Res."},{"issue":"2","key":"10.1016\/j.cct.2026.108219_bb0235","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0962280210379079","article-title":"Statistical approaches to analyse patient-reported outcomes as response variables: an application to health-related quality of life","volume":"21","author":"Arostegui","year":"2012","journal-title":"Stat. Methods Med. Res."},{"issue":"2","key":"10.1016\/j.cct.2026.108219_bb0240","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand. J. Stat."},{"issue":"5","key":"10.1016\/j.cct.2026.108219_bb0245","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41366-020-00733-x","article-title":"Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data","volume":"45","author":"Wharton","year":"2021","journal-title":"Int. J. Obes."},{"issue":"17","key":"10.1016\/j.cct.2026.108219_bb0250","first-page":"e426","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.cct.2026.108219_bb0255","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1108660","article-title":"Comparative effectiveness of weight-loss interventions in clinical practice","volume":"365","author":"Appel","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.cct.2026.108219_bb0260","first-page":"1566","article-title":"Wing RR: long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the look AHEAD trial","volume":"170","author":"Look Ahead Research Group","year":"2010","journal-title":"Arch. Intern. Med."},{"issue":"9774","key":"10.1016\/j.cct.2026.108219_bb0265","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.cct.2026.108219_bb0270","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.cct.2026.108219_bb0275","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/HYPERTENSIONAHA.117.10479","article-title":"Blood pressure measurement in SPRINT (systolic blood pressure intervention trial)","volume":"71","author":"Johnson","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.cct.2026.108219_bb0280","series-title":"National Health and Nutrition Examination Survey Data","author":"(NCHS) CfDCaPCNCfHS","year":"2021"},{"issue":"10","key":"10.1016\/j.cct.2026.108219_bb0285","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","article-title":"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial","volume":"28","author":"Garvey","year":"2022","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.cct.2026.108219_bb0290","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of weekly subcutaneous Semaglutide vs daily Liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial","volume":"327","author":"Rubino","year":"2022","journal-title":"Jama"},{"issue":"14","key":"10.1016\/j.cct.2026.108219_bb0295","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous Semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.cct.2026.108219_bb0300","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly Semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cct.2026.108219_bb0305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with Semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cct.2026.108219_bb0310","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cct.2026.108219_bb0315","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/s41591-024-02883-1","article-title":"Author correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial","volume":"30","author":"Wadden","year":"2024","journal-title":"Nat. Med."},{"issue":"15 Suppl","key":"10.1016\/j.cct.2026.108219_bb0320","first-page":"S307","article-title":"Managed care considerations of weight management interventions for obesity","volume":"28","author":"Amaro","year":"2022","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.cct.2026.108219_bb0325","series-title":"Impact of Anti-Obesity Medication Coverage in Medicare Part D","author":"Report","year":"2024"},{"issue":"6","key":"10.1016\/j.cct.2026.108219_bb0330","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/oby.24290","article-title":"Perceptions of anti-obesity medications among people with obesity and healthcare providers in the US: findings from the OBSERVE study","volume":"33","author":"Kaplan","year":"2025","journal-title":"Obesity (Silver Spring)"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426000054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426000054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T11:33:16Z","timestamp":1782041596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714426000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":65,"alternative-id":["S1551714426000054"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2026.108219","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The long-term effectiveness of the anti-obesity medication phentermine (LEAP) trial: Rationale, design, and baseline characteristics","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2026.108219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108219"}}